HKU Scholars Hub: Browsing DSpace

Browsing by Author Mok, CKP

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 10 of 10

	Title	Author(s)	Issue Date	Views
	A Randomized Clinical Trial Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac Journal:American Journal of Respiratory and Critical Care Medicine	Mok, CKP Chen, C Yiu, K Chan, T Lai, KC Ling, KC Sun, Y Hui, DS Cheng, MS Peiris, JSM	2022
	Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines Journal:Signal transduction and targeted therapy	Peng, Y Zhang, L Mok, CKP Ching, JYL Zhao, SL Wong, MKL Zhu, J Chen, CK Wang, SL Yan, S Qin, BY Liu, YZ Zhang, X Cheung, CP Cheong, PK Ip, KL Fung, ACH Wong, KKY Hui, DSC Chan, FKL Ng, SC Tun, HM	25-Sep-2023
	Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong Journal:Respirology	Mok, CKP Cohen, CA Cheng, MS Chen, C Kwok, K Yiu, K Chan, T Bull, MB Ling, KC Dai, ZX Ng, SS Lui, GCY Wu, C Amarasinghe, GK Leung, DW Wong, SYS Doak, SAV Peiris, JSM Hui, DS	2022
	Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events Journal:Gut	NG, SC PENG, Y ZHANG, L MOK, CKP Zhao, S LI, A CHING, JYL LIU, YZ YAN, S CHAN, DLS Zhu, J CHEN, C FUNG, ACH WONG, KKY HUI, DSC CHAN, FKL Tun, HM	2022	7
	Neutralizing Antibody Response to Sarbecovirus Is Delayed in Sequential Heterologous Immunization Journal:Viruses	Lyu, H So, TY TEO, QW Yuan, M Liu, H Lee, CD YIP, KWG Ng, WW Wilson, IA Peiris, JSM Wu, NC Mok, CKP	2022
	Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection Journal:Journal of Clinical Virology	Cheng, MS Mok, CKP Li, KC Ng, SS Lam, BHS Jeevan, T Kandeil, A Pekosz, A Chan, CKK Tsang, CH Ko, FW Chen, C Yiu, K Luk, LH Chan, KKP Webby, RJ Poon, LML Hui, DSC Peiris, JSM	2022
	Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses Journal:Nature Communications	Jia, Z Tan, CW Cheng, MS Gu, H Yeoh, AYY Mok, CKP Wang, Y Zhao, J Leung, NHL Cowling, BJ Poon, LML Hui, DSC Wang, L Peiris, JSM Doak, SAV	2022
	SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022 Journal:Eurosurveillance	Cheng, MS Mok, CKP Chan, CKK Ng, SS Lam, BHS Luk, LH Ko, FW Chen, C Yiu, K Li, KC Chan, KKP Tsang, CH Poon, LML Hui, DSC Peiris, JSM	2022
	Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir Journal:ACS Central Science	Lo, HS Hui, KPY Lai, HM He, X Khan, KS Kaur, S Huang, J Li, Z Chan, AKN Cheung, HHY Ng, KC Ho, JCW Chen, YW Ma, B Cheung, PMH Shin, D Wang, K Lee, MH Selisko, B Eydoux, C Guillemot, JC Canard, B Wu, KP Liang, PH Dikic, I Zuo, Z Chan, FK Hui, DSC Mok, VC Wong, KB Mok, CKP Ko, H Aik, WS Chan, MCW Ng, WL	2021	13
	Universal influenza vaccinia vaccine requires CD4+ T cells for heterosubtypic protection Proceeding/Conference:ISIRV Options-8 Conference	Doak, SA Li, OTW Mak, PWY Mok, CKP Nicholls, JM Peiris, JSM Perera, LIP Poon, LLM	2013	25

Showing results 1 to 10 of 10